INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES
-
Critical Imaging Risks In GLP-1 And Neurology Studies
As imaging grows in importance within GLP-1 and neurology trials, it must be treated not as a routine task but as a strategic pillar that supports participant safety and reproducible outcomes.
-
Rare Disease Prioritization Model And Landscape Analysis
Uncover how a global pharmaceutical company seeking to identify promising indications among rare diseases to develop preclinical candidate molecules received an in-depth disease analysis to guide its strategic decision-making.
-
How Strategic LQPPV Outsourcing Future-Proofs PV Compliance In The AI Era
As health authorities seek standardization across global processes and strong AI governance, working with an experienced PV partner will help minimize the burden of oversight and ensure compliance.
-
Simply Digital: Trial Technologies Help Reduce Oncology's Burden
Oncology trials are notorious for presenting participants and sites with many challenges. With the FDA having put its support behind digital tools, learn how they make oncology trials easier for everyone.
-
Scout Belongs In Your eClinical Solution Suite9/3/2025
Traditional eClinical platforms manage data, but not participation. Learn how to fill the gap with travel, payments, and support that keep patients engaged, sites focused, and trials moving forward.
-
Navigating Multisite Trials8/21/2025
Overcome data challenges in multisite clinical trials with strategies that ensure consistency, regulatory compliance, and accurate, reliable results.
-
Hidden Costs Of Data Cleaning: Build Quality At The Source12/11/2025
Hidden costs from downstream data cleaning slow trials and raise risk. Explore why building quality at the source accelerates timelines, reduces errors, and gives sponsors a competitive edge.
-
Breaking Barriers With PCR: Innovative Solutions For Clinical Trial Success9/3/2025
This presentation brings together experts from Precision for Medicine, Avidity Biosciences, and Indaptus Therapeutics to examine the expanding role of PCR-based molecular monitoring.
-
Accelerating DHT Research And Drug Development12/19/2024
This presentation focuses on the scope and utility of the National Health and Nutrition Examination Survey, a program of studies designed to assess the health status of individuals in the United States.
CLINICAL TRIAL TECHNOLOGY SOLUTIONS
-
Site Cloud: End of Study is the first end-to-end solution that seamlessly generates, distributes & manages sites’ study files at the end of a study. With EOS, sites’ study files are accessible and downloadable via a secure and trusted unified platform, eliminating the need to create and distribute physical media and deal with paper acknowledgment forms.
-
Learn about a sophisticated suite of pharmacokinetic (PK) and pharmacometric services designed to accelerate and optimize early-phase drug development.
-
Sponsors can maximize the predictive capabilities in Citeline Predict: Study Feasibility by incorporating their data assets into our ML models. In doing so, they will realize improvements in both clinical trial KPIs and feasibility workflow.
-
This platform benefits sponsors seeking faster study cycles and regulatory compliance, CROs, MedTech companies, and research sites globally.
-
Effortlessly distribute, monitor, and exchange study documents with every site—wherever they work, whenever they need it.
Other tools promise site connections, but they can't deliver 100% coverage with a solution sites actually want.
Adoption
They claim sites use their tool…but you need sites to love it.
Tracking
They let you send documents…but you need to know the status of every document at every site.
Integration
They offer integration within their ecosystem…but you need compatibility with every site and sponsor software.